Last updated on March 2018

A clinical trial seeking patients for a research study for the treatment of Cerebral Arteriovenous Malformation


Brief description of study

To assess safety and efficacy of ONYX treatment for cAVM:

Detailed Study Description

The main objective of this study is to assess the safety at 1 month after any embolization session and the efficacy at:

  • 12 months post last embolization in case of treatment with embolization only
  • 12 months after additional treatment with neurosurgery
  • 36 months after additional treatment with radiosurgery

Clinical Study Identifier: NCT02180958

Contact Investigators or Research Sites near you

Start Over

Covidien
Paris, France